SCHEMBL4716630

SCHEMBL4716630

O=C(O)N1CCC(CCOc2cncc(-c3cccc(N4Cc5cccc(Cl)c5C4=O)c3)c2)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 2/20 0.41
HTR2C P28335 2/20 0.41
HTR2B P41595 2/20 0.41
BDKRB1 P46663 1/20 0.41
FAAH O00519 1/20 0.38
ITGB3 P05106 2/20 0.36
ITGA2B P08514 2/20 0.36
TEAD1 P28347 1/20 0.35
TEAD3 Q99594 1/20 0.35
NR1H4 Q96RI1 1/20 0.35
CHRNB1 P11230 2/20 0.34
CHRNB2 P17787 2/20 0.34
CHRNB4 P30926 2/20 0.34
CHRNA3 P32297 2/20 0.34
CHRNB3 Q05901 2/20 0.34
PARP1 P09874 1/20 0.34
PRMT5 O14744 2/20 0.33
WDR77 Q9BQA1 2/20 0.33
PPARG P37231 1/20 0.33
PPARD Q03181 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5628644 0.90 GPR119 (0.40) HTR2AHTR2CHTR2BBDKRB1FAAH
SCHEMBL5632155 0.88 BDKRB1 (0.48) HTR2AHTR2CHTR2BBDKRB1HRH3
SCHEMBL4716498 0.87 AKT1 (0.41) HTR2AHTR2CHTR2BBDKRB1ITGB3
SCHEMBL4712314 0.80 BDKRB1 (0.49) HTR2AHTR2CHTR2BBDKRB1CHRNB1
SCHEMBL4714752 0.79 HTR2A (0.40) HTR2AHTR2CHTR2BBDKRB1CHRNB1
SCHEMBL4715875 0.78 NPBWR1 (0.42) BDKRB1PRMT5WDR77
SCHEMBL4711961 0.75 HTR6 (0.44) HTR2AHTR2CHTR2BBDKRB1PARP1
SCHEMBL5630710 0.74 BDKRB1 (0.48) HTR2AHTR2CHTR2BBDKRB1
SCHEMBL4717297 0.73 PARP1 (0.40) HTR2AHTR2CHTR2BBDKRB1ITGB3
SCHEMBL4711860 0.72 BDKRB1 (0.51) HTR2AHTR2CHTR2BBDKRB1PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1877401-A2 NOVEL COMPOUNDS USEFUL FOR BRADYKININ B1 RECEPTOR ANTAGONISM Elan Pharmaceuticals Inc. (US) 2008-01-16 EP disclosed
WO-2006113140-A2 NOVEL COMPOUNDS USEFUL FOR BRADYKININ B1 RECEPTOR ANTAGONISM ELAN PHARMACEUTICALS, INC. (US) 2006-10-26 WO disclosed